WGS
GeneDx Holdings Corp

4,468
Mkt Cap
$2.52B
Volume
1.14M
52W High
$170.87
52W Low
$55.17
PE Ratio
1,444.11
WGS Fundamentals
Price
$80.70
Prev Close
$87.08
Open
$84.02
50D MA
$114.12
Beta
1.47
Avg. Volume
722,901.85
EPS (Annual)
-$0.7339
P/B
8.61
Rev/Employee
$328,876.15
$3,667.03
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of -$0.61 down -405.00% YoY • Reported revenue of $120.99M up 26.50% YoY

Bullish

GeneDx achieved significant revenue and gross profit growth in 2025, driven by increased exome and genome test volumes and strategic acquisition of Fabric Genomics' AI platform, enhancing its market position.

Bearish

GeneDx faces risks from evolving FDA oversight of LDTs, a material weakness in internal controls, and reliance on limited suppliers, which could lead to compliance delays, financial misstatements, and operational disruptions.

Latest WGS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.